Orgenesis Inc. (ORGS): Price and Financial Metrics
Orgenesis Inc. (ORGS)
Today's Latest Price: $5.95 USD
0.01 (0.17%)
Updated Jul 7 4:00pm
Add ORGS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 214 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ORGS Stock Summary
- ORGS's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.27 -- higher than merely 5.07% of US-listed equities with positive expected earnings growth.
- With a year-over-year growth in debt of -32.64%, Orgenesis Inc's debt growth rate surpasses merely 8.77% of about US stocks.
- In terms of twelve month growth in earnings before interest and taxes, Orgenesis Inc is reporting a growth rate of 295.98%; that's higher than 95.27% of US stocks.
- If you're looking for stocks that are quantitatively similar to Orgenesis Inc, a group of peers worth examining would be BGMD, XXII, ADMP, HCAT, and DMRC.
- ORGS's SEC filings can be seen here. And to visit Orgenesis Inc's official web site, go to www.orgenesis.com.
ORGS Daily Price Range
ORGS 52-Week Price Range
ORGS Stock Price Chart Technical Analysis Charts
ORGS Price/Volume Stats
| Current price | $5.95 | 52-week high | $8.20 |
| Prev. close | $5.94 | 52-week low | $2.35 |
| Day low | $5.64 | Volume | 74,114 |
| Day high | $6.00 | Avg. volume | 113,574 |
| 50-day MA | $6.54 | Dividend yield | N/A |
| 200-day MA | $4.59 | Market Cap | 130.88M |
Orgenesis Inc. (ORGS) Company Bio
Orgenesis Inc., a service and research company, focus on the development and manufacture of cell therapy for advanced medicinal products in the field of regenerative medicine industry. The company was founded in 2008 and is based in Germantown, Maryland.
Loading social stream, please wait...